As a CRO (Contract Research Organization), Tergus provides topical pharmaceutical R&D, testing and manufacturing services to companies of all sizes with agile and custom solutions. The industry experts in our team apply QbD (Quality by Design) principles to help you with formulation development, analysis, testing and clinical supply manufacturing. We excel in providing you with the best solution and take immense care in risk mitigation strategies.
Topical Formulation DevelopmentTergus Pharma is a One-Stop Solution for all of Your Topical Formulation Development Needs.
Manufacturing FacilityTergus has a state-of-the-art semi-solid manufacturing facility and extensive expertise in the management and...
IVRT (Franz Diffusion)Tergus Pharma provides significant expertise in In vitro Release Rate Test (IVRT) Method Development & Validation.
- Dawn Slann joined Tergus effective June 11, 2018 in the capacity of Senior Director, Quality Assurance.
June 13, 2018)
- Tergus Announces Key Leadership Changes
April 25, 2018)
- Joint Life Science Caucus Visits the NC Research Campus
(April 06, 2018)
- Tergus Pharma announces the Acquisition of EnDev Labs
(March 22, 2018)